Skip to content
2000
Volume 7, Issue 1
  • ISSN: 1389-5575
  • E-ISSN: 1875-5607

Abstract

The currently available drugs for long-term treatment of obesity are sibutramine and orlistat. They have been shown to be able to induce significant weight loss, with important co-morbidity reduction, allowing the maintenance of reduced body weight for at least 1-2 years. Cardiostimulating and gastrointestinal adverse effects are however not negligible.

Loading

Article metrics loading...

/content/journals/mrmc/10.2174/138955707779317849
2007-01-01
2024-11-14
Loading full text...

Full text loading...

/content/journals/mrmc/10.2174/138955707779317849
Loading

  • Article Type:
    Research Article
Keyword(s): body weight; diet; energy balance; fat; orlistat; Pharmacotherapy; physical activity; sibutramine
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test